| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2015-02-16 | OpRegen® | geographic atrophy |
1-2a | Cell Cure Neurosciences (Israel) Biotime (USA - CA) | Ophtalmological diseases |
| 2015-02-13 | Actimmune® (interferon gamma-1b) | Friedreich\'s ataxia |
3 | Horizon Pharma (Ireland) | Rare diseases - Genetic diseases - Neurodegenerative diseases |
| 2015-02-13 | glasdegib - PF-06463922 | myelodysplastic syndrome, acute myeloid leukemia | 1-2 | Pfizer (USA - NY) | Cancer - Oncology |
| 2015-02-13 | BioThrax® (Anthrax Vaccine Adsorbed) | prevention of anthrax disease |
non clinical | Emergent BioSolutions (USA - MD) | Infectious diseases |
| 2015-02-12 | Cerdelga® (eliglustat tartrate) | Gaucher's disease |
3 | Genzyme (USA - MA), a Sanofi company (France) | Rare diseases - Genetic diseases |
| 2015-02-12 | olipudase alfa | Niemann-Pick Disease type B | 1b | Genzyme (USA - MA), a Sanofi company (France) | Rare diseases - Genetic diseases |
| 2015-02-12 | BAX 335 | hemophilia B |
1-2 | Baxter (USA - IL) | Hematological diseases - Genetic diseases - Rare diseases |
| 2015-02-12 | Elelyso® (taliglucerase alfa) | Type 1 Gaucher Disease |
pediatric | Pfizer (USA - NY) | Rare diseases - Genetic diseases |
| 2015-02-11 | QuantiFERON-TB Gold (QFT®) | tuberculosis |
Qiagen (The Netherlands) | Infectious diseases | |
| 2015-02-10 | FRM-0334 | frontotemporal dementia with granulin mutation (FTD-GRN) |
2a | Forum Pharmaceuticals (USA - MA) | Rare diseases - Neurodegenerative diseases |
| 2015-02-10 | ixazomib (MLN9708 - 2,2'-{2-[(1R)-1-({[(2,5-dichlorobenzoyl)amino]acetyl}amino)-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diacetic acid) | relapsed or refractory multiple myeloma | 3 | Takeda Pharmaceutical (Japan) Millennium Pharmaceuticals (USA - MA) | Cancer - Oncology - Rare diseases |
| 2015-02-10 | Rapid Ebola Virus Triage Test | Ebola fever |
Biocartis (Switzerland) Janssen Diagnostics, a J&J company (USA - NJ) the Institute for Tropical Medicine (Belgium) | Diagnostic - Infectious diseases | |
| 2015-02-10 | migalastat | Fabry disease | 3 | GSK (UK) Amicus Therapeutics (USA - NJ) | Rare diseases - Genetic diseases |
| 2015-02-09 | BMS-663068 (fostemsavir) | HIV/AIDS | 3 | BMS (USA - NY) | Infectious diseases |
| 2015-02-09 | masitinib | Alzheimer's disease | 3 | AB Science (France) | Neurodegenerative diseases |
| 2015-02-09 | ADU-741 | prostate cancer |
1 | Janssen Biotech, a J&J company (USA - NJ) - Aduro Biotech (USA - CA) | Cancer - Oncology |
| 2015-02-09 | CG0070 | high grade non-muscle invasive bladder cancer (NMIBC) after failure of BCG therapy | 3 | Cold Genesys (USA - CA) | Cancer - Oncology |
| 2015-02-05 | HinsBet® (fast-acting human insulin) | type 1 diabetes | 2a | Adocia (France) | Metabolic diseases |
| 2015-02-05 | VLX1570 and dexamethasone | multiple myeloma | 1-2 | Vivolux (USA - Sweden) | Cancer - Oncology |
| 2015-02-05 | ProCervix® | treatment of adult women already infected with human papillomavirus (HPV) genotype 16 or 18
|
1 | Genticel (France) | Infectious diseases |
